Five-year survival after transcatheter chemoembolization for hepatocellular carcinoma.
Nakamura H, Mitani T, Murakami T, Hashimoto T, Tsuda K, Nakanishi K, Ishida T, Tomoda K, Hori S, Kozuka T, et al.
Nakamura H, et al. Among authors: tsuda k.
Cancer Chemother Pharmacol. 1994;33 Suppl:S89-92. doi: 10.1007/BF00686675.
Cancer Chemother Pharmacol. 1994.
PMID: 8137491